Eli Lilly sues Par Pharmaceutical over testosterone treatment

24-04-2017

Eli Lilly sues Par Pharmaceutical over testosterone treatment

BrianAJackson / iStockphoto.com

Eli Lilly has sued Par Pharmaceutical for patent infringement over the drug Axiron (testosterone), used to treat men with low or no testosterone.


Eli Lilly, patent, ANDA, FDA, Axiron, testosterone, Par Pharmaceutical

LSIPR